A twice-yearly injectable drug for the prevention of HIV infection has been approved by the United States’ Food and Drug ...

A major win in the fight against HIV infections. The Food and Drug Administration approved a new twice-a-year shot to prevent ...

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The FDA has approved Gilead Sciences' twice-yearly injection to prevent HIV, a move the company hailed as a major ...

The U.S. Food and Drug Administration approved an HIV prevention medication that has been proven highly effective in clinical ...